These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36289810)

  • 1. Combinations of Cannabidiol and Δ
    Sepulveda DE; Vrana KE; Graziane NM; Raup-Konsavage WM
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
    Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
    Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
    J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis constituent synergy in a mouse neuropathic pain model.
    Casey SL; Atwal N; Vaughan CW
    Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
    Ryan D; Drysdale AJ; Pertwee RG; Platt B
    Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combined effects of Δ
    King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
    Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis.
    Maayah ZH; Takahara S; Ferdaoussi M; Dyck JRB
    Inflamm Res; 2020 Jun; 69(6):549-558. PubMed ID: 32239248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment.
    Dumbraveanu C; Strommer K; Wonnemann M; Choconta JL; Neumann A; Kress M; Kalpachidou T; Kummer KK
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A type II cannabis extract and a 1:1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space.
    Benredjem B; Pineyro G
    Front Pharmacol; 2023; 14():1235255. PubMed ID: 37745077
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
    Nahler G
    Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
    Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
    Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemical Comparison of Medicinal Cannabis Extracts and Study of Their CYP-Mediated Interactions with Coumarinic Oral Anticoagulants.
    Treyer A; Reinhardt JK; Eigenmann DE; Oufir M; Hamburger M
    Med Cannabis Cannabinoids; 2023; 6(1):21-31. PubMed ID: 36814687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.